nodes	percent_of_prediction	percent_of_DWPC	metapath
Natamycin—Hyperaemia—Timolol—coronary artery disease	0.054	0.054	CcSEcCtD
Natamycin—Sensation of foreign body—Timolol—coronary artery disease	0.05	0.05	CcSEcCtD
Natamycin—Lacrimation—Enalapril—coronary artery disease	0.0379	0.0379	CcSEcCtD
Natamycin—Lacrimation—Perindopril—coronary artery disease	0.0353	0.0353	CcSEcCtD
Natamycin—Eye irritation—Lovastatin—coronary artery disease	0.0319	0.0319	CcSEcCtD
Natamycin—Lacrimation—Timolol—coronary artery disease	0.0277	0.0277	CcSEcCtD
Natamycin—Lacrimation increased—Enalapril—coronary artery disease	0.0242	0.0242	CcSEcCtD
Natamycin—Lacrimation increased—Perindopril—coronary artery disease	0.0225	0.0225	CcSEcCtD
Natamycin—Eye irritation—Timolol—coronary artery disease	0.0191	0.0191	CcSEcCtD
Natamycin—Lacrimation increased—Timolol—coronary artery disease	0.0177	0.0177	CcSEcCtD
Natamycin—Hypersensitivity—Tirofiban—coronary artery disease	0.0159	0.0159	CcSEcCtD
Natamycin—Dyspnoea—Penbutolol—coronary artery disease	0.0136	0.0136	CcSEcCtD
Natamycin—Chest pain—Gemfibrozil—coronary artery disease	0.0136	0.0136	CcSEcCtD
Natamycin—Hypersensitivity—Pitavastatin—coronary artery disease	0.0136	0.0136	CcSEcCtD
Natamycin—Chest pain—Ticagrelor—coronary artery disease	0.0133	0.0133	CcSEcCtD
Natamycin—Eye pain—Timolol—coronary artery disease	0.0131	0.0131	CcSEcCtD
Natamycin—Paraesthesia—Gemfibrozil—coronary artery disease	0.0117	0.0117	CcSEcCtD
Natamycin—Chest pain—Acetylsalicylic acid—coronary artery disease	0.0116	0.0116	CcSEcCtD
Natamycin—Paraesthesia—Ticagrelor—coronary artery disease	0.0114	0.0114	CcSEcCtD
Natamycin—Dyspnoea—Ticagrelor—coronary artery disease	0.0113	0.0113	CcSEcCtD
Natamycin—Chest pain—Fenofibrate—coronary artery disease	0.0104	0.0104	CcSEcCtD
Natamycin—Paraesthesia—Rosuvastatin—coronary artery disease	0.0103	0.0103	CcSEcCtD
Natamycin—Chest pain—Clopidogrel—coronary artery disease	0.0102	0.0102	CcSEcCtD
Natamycin—Chest pain—Lovastatin—coronary artery disease	0.0101	0.0101	CcSEcCtD
Natamycin—Chest pain—Ezetimibe—coronary artery disease	0.00994	0.00994	CcSEcCtD
Natamycin—Dyspnoea—Acetylsalicylic acid—coronary artery disease	0.00992	0.00992	CcSEcCtD
Natamycin—Chest pain—Eplerenone—coronary artery disease	0.00972	0.00972	CcSEcCtD
Natamycin—Chest pain—Simvastatin—coronary artery disease	0.00947	0.00947	CcSEcCtD
Natamycin—Hypersensitivity—Ticagrelor—coronary artery disease	0.00938	0.00938	CcSEcCtD
Natamycin—Chest pain—Valsartan—coronary artery disease	0.00895	0.00895	CcSEcCtD
Natamycin—Paraesthesia—Fenofibrate—coronary artery disease	0.00893	0.00893	CcSEcCtD
Natamycin—Chest pain—Olmesartan—coronary artery disease	0.0089	0.0089	CcSEcCtD
Natamycin—Dyspnoea—Fenofibrate—coronary artery disease	0.00887	0.00887	CcSEcCtD
Natamycin—Paraesthesia—Clopidogrel—coronary artery disease	0.00878	0.00878	CcSEcCtD
Natamycin—Paraesthesia—Lovastatin—coronary artery disease	0.00872	0.00872	CcSEcCtD
Natamycin—Dyspnoea—Clopidogrel—coronary artery disease	0.00872	0.00872	CcSEcCtD
Natamycin—Dyspnoea—Lovastatin—coronary artery disease	0.00866	0.00866	CcSEcCtD
Natamycin—Chest pain—Pravastatin—coronary artery disease	0.00857	0.00857	CcSEcCtD
Natamycin—Paraesthesia—Ezetimibe—coronary artery disease	0.00855	0.00855	CcSEcCtD
Natamycin—Dyspnoea—Ezetimibe—coronary artery disease	0.00849	0.00849	CcSEcCtD
Natamycin—Hypersensitivity—Rosuvastatin—coronary artery disease	0.00844	0.00844	CcSEcCtD
Natamycin—Chest pain—Trandolapril—coronary artery disease	0.00832	0.00832	CcSEcCtD
Natamycin—Dyspnoea—Eplerenone—coronary artery disease	0.00831	0.00831	CcSEcCtD
Natamycin—Chest pain—Enalapril—coronary artery disease	0.00829	0.00829	CcSEcCtD
Natamycin—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.0082	0.0082	CcSEcCtD
Natamycin—Chest pain—Telmisartan—coronary artery disease	0.00817	0.00817	CcSEcCtD
Natamycin—Paraesthesia—Simvastatin—coronary artery disease	0.00816	0.00816	CcSEcCtD
Natamycin—Dyspnoea—Simvastatin—coronary artery disease	0.0081	0.0081	CcSEcCtD
Natamycin—Chest pain—Captopril—coronary artery disease	0.00795	0.00795	CcSEcCtD
Natamycin—Chest pain—Perindopril—coronary artery disease	0.00772	0.00772	CcSEcCtD
Natamycin—Paraesthesia—Valsartan—coronary artery disease	0.0077	0.0077	CcSEcCtD
Natamycin—Dyspnoea—Valsartan—coronary artery disease	0.00765	0.00765	CcSEcCtD
Natamycin—Paraesthesia—Niacin—coronary artery disease	0.00749	0.00749	CcSEcCtD
Natamycin—Dyspnoea—Niacin—coronary artery disease	0.00744	0.00744	CcSEcCtD
Natamycin—Paraesthesia—Pravastatin—coronary artery disease	0.00737	0.00737	CcSEcCtD
Natamycin—Hypersensitivity—Fenofibrate—coronary artery disease	0.00733	0.00733	CcSEcCtD
Natamycin—Dyspnoea—Pravastatin—coronary artery disease	0.00732	0.00732	CcSEcCtD
Natamycin—Chest pain—Losartan—coronary artery disease	0.00724	0.00724	CcSEcCtD
Natamycin—Hypersensitivity—Clopidogrel—coronary artery disease	0.0072	0.0072	CcSEcCtD
Natamycin—Paraesthesia—Trandolapril—coronary artery disease	0.00716	0.00716	CcSEcCtD
Natamycin—Hypersensitivity—Lovastatin—coronary artery disease	0.00715	0.00715	CcSEcCtD
Natamycin—Paraesthesia—Enalapril—coronary artery disease	0.00713	0.00713	CcSEcCtD
Natamycin—Dyspnoea—Trandolapril—coronary artery disease	0.00711	0.00711	CcSEcCtD
Natamycin—Dyspnoea—Enalapril—coronary artery disease	0.00708	0.00708	CcSEcCtD
Natamycin—Paraesthesia—Telmisartan—coronary artery disease	0.00703	0.00703	CcSEcCtD
Natamycin—Hypersensitivity—Ezetimibe—coronary artery disease	0.00702	0.00702	CcSEcCtD
Natamycin—Dyspnoea—Telmisartan—coronary artery disease	0.00698	0.00698	CcSEcCtD
Natamycin—Paraesthesia—Captopril—coronary artery disease	0.00684	0.00684	CcSEcCtD
Natamycin—Dyspnoea—Captopril—coronary artery disease	0.00679	0.00679	CcSEcCtD
Natamycin—Hypersensitivity—Simvastatin—coronary artery disease	0.00669	0.00669	CcSEcCtD
Natamycin—Paraesthesia—Perindopril—coronary artery disease	0.00664	0.00664	CcSEcCtD
Natamycin—Dyspnoea—Perindopril—coronary artery disease	0.00659	0.00659	CcSEcCtD
Natamycin—Paraesthesia—Furosemide—coronary artery disease	0.00646	0.00646	CcSEcCtD
Natamycin—Hypersensitivity—Valsartan—coronary artery disease	0.00632	0.00632	CcSEcCtD
Natamycin—Paraesthesia—Losartan—coronary artery disease	0.00623	0.00623	CcSEcCtD
Natamycin—Chest pain—Ramipril—coronary artery disease	0.00621	0.00621	CcSEcCtD
Natamycin—Dyspnoea—Losartan—coronary artery disease	0.00618	0.00618	CcSEcCtD
Natamycin—Hypersensitivity—Niacin—coronary artery disease	0.00614	0.00614	CcSEcCtD
Natamycin—Chest pain—Timolol—coronary artery disease	0.00607	0.00607	CcSEcCtD
Natamycin—Hypersensitivity—Pravastatin—coronary artery disease	0.00605	0.00605	CcSEcCtD
Natamycin—Hypersensitivity—Trandolapril—coronary artery disease	0.00588	0.00588	CcSEcCtD
Natamycin—Hypersensitivity—Enalapril—coronary artery disease	0.00585	0.00585	CcSEcCtD
Natamycin—Hypersensitivity—Telmisartan—coronary artery disease	0.00577	0.00577	CcSEcCtD
Natamycin—Chest pain—Lisinopril—coronary artery disease	0.00563	0.00563	CcSEcCtD
Natamycin—Paraesthesia—Ramipril—coronary artery disease	0.00534	0.00534	CcSEcCtD
Natamycin—Dyspnoea—Ramipril—coronary artery disease	0.0053	0.0053	CcSEcCtD
Natamycin—Hypersensitivity—Furosemide—coronary artery disease	0.0053	0.0053	CcSEcCtD
Natamycin—Paraesthesia—Timolol—coronary artery disease	0.00522	0.00522	CcSEcCtD
Natamycin—Dyspnoea—Timolol—coronary artery disease	0.00518	0.00518	CcSEcCtD
Natamycin—Hypersensitivity—Losartan—coronary artery disease	0.00511	0.00511	CcSEcCtD
Natamycin—Paraesthesia—Lisinopril—coronary artery disease	0.00484	0.00484	CcSEcCtD
Natamycin—Dyspnoea—Lisinopril—coronary artery disease	0.00481	0.00481	CcSEcCtD
Natamycin—Hypersensitivity—Ramipril—coronary artery disease	0.00438	0.00438	CcSEcCtD
Natamycin—Hypersensitivity—Timolol—coronary artery disease	0.00428	0.00428	CcSEcCtD
Natamycin—Hypersensitivity—Lisinopril—coronary artery disease	0.00397	0.00397	CcSEcCtD
